Skip to content

Menu

  • About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Calendar

July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
« Jun    

Categories

  • Current Affairs
  • Finance
  • World News

Copyright BlogSone 2025 | Theme by ThemeinProgress | Proudly powered by WordPress

BlogSone
  • About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy
You are here :
  • Home
  • Current Affairs
  • India’s New Weapon In opposition to Malaria
Written by BlogsoneJuly 24, 2025

India’s New Weapon In opposition to Malaria

Current Affairs Article


Malaria Burden and New Hope

  • Malaria kills ~400,000 globally per yr, with India contributing considerably regardless of sharp latest declines.
  • ICMR declares a promising candidate vaccine (AfaDixVax) for Plasmodium falciparum, to be co-developed with non-public gamers for industrial use.
  • Although P. falciparum is extra deadly, India’s circumstances are largely as a result of P. vivax, towards which AfaDixVax is ineffective.

Relevance : GS 2(Well being , Governance )

Declining Development in India (1995–2022)

  • Reported malaria circumstances dropped from 2.93 million (1995) to simply 0.18 million (2022).
  • Deaths fell drastically from 1,151 (1995) to simply 83 (2022).
  • These enhancements are as a result of enhanced surveillance by NVBDCP and WHO assist, although actual numbers could also be underreported.

What’s AfaDixVax and Why it Issues

  • Targets two P. falciparum proteins (PfCSP and Pf34/Pf48.5) utilizing the PfCo6 protein technique to stop liver-stage an infection.
  • Demonstrated 90%+ safety in mice for over three months—translating to just about a decade in people, per ICMR.
  • Early animal research present strong, longer-lasting immunity, higher than different vaccines.

Adjuvant & Security Benefit

  • Accommodates alum as adjuvant—extensively utilized in childhood vaccines, protected and avoids power irritation dangers.
  • In comparison with WHO-approved RTS,S and R21, AfaDixVax:
    • Doesn’t depend on CSP protein, lowering breakthrough an infection threat.
    • Induces stronger safety in pre-clinical fashions.
    • Might be saved at room temperature for months, doubtlessly fixing chilly chain challenges.

Manufacturing, IP, and Business Path

  • ICMR will develop and check the vaccine, and accomplice with trade for manufacturing and industrial rollout.
  • IP rights shall be collectively held by ICMR and the accomplice, however ICMR retains all knowledge and rights for non-commercial use.

World Context & India’s Position

  • Malaria is most endemic in Africa, however India’s innovation could assist world struggle, particularly with scalable, heat-stable vaccines.
  • AfaDixVax provides to India’s rising position in world well being innovation, vaccine self-reliance, and public-private partnership fashions.

You may also like

“Realities behind the worldwide experiment of ‘distant work’”

ICMR Pushes Diagnostics Decentralisation Throughout States

India Can Reframe the Synthetic Intelligence Debate

Tags: Indias, Malaria, weapon

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Calendar

July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
« Jun    

Categories

  • Current Affairs
  • Finance
  • World News

https://blogsone.site/ - All Rights Reserved | Theme by ThemeinProgress | Proudly powered by WordPress